chuminhua2019-01-03 23:08
$Ohr制药(OHRP)$
12/3,NeuBase Therapeutics通过反向收购Ohr Pharmaceutical,在纳斯达克上市。NeuBase的模块化反义肽核酸(PNA)平台PATrOL用于改善基因沉默疗法。网页链接查看全文
$Ohr Pharmaceuticals, Inc.(OHRP)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-05-15 AccNo: 0001387131-18-002211 Size: 1 MB 网页链接
$Ohr Pharmaceuticals, Inc.(OHRP)$ 8-K - Current report Filed: 2018-05-15 AccNo: 0001387131-18-002194 Size: 58 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Ohr Pharmaceuticals, Inc.(OHRP)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-05-15 AccNo: 0001387131-18-002211 Size: 1 MB 网页链接
$Ohr Pharmaceuticals, Inc.(OHRP)$ 8-K - Current report Filed: 2018-05-15 AccNo: 0001387131-18-002194 Size: 58 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Ohr Pharmaceuticals, Inc.(OHRP)$ 8-K - Current report Filed: 2018-02-23 AccNo: 0001387131-18-000769 Size: 27 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 网页链接
$Ohr Pharmaceuticals, Inc.(OHRP)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-02-15 AccNo: 0001387131-18-000710 Size: 140 KB 网页链接
$Ohr Pharmaceuticals, Inc.(OHRP)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-02-14 AccNo: 0001387131-18-000667 Size: 1 MB 网页链接
$Ohr Pharmaceuticals, Inc.(OHRP)$ 8-K - Current report Filed: 2018-02-14 AccNo: 0001387131-18-000666 Size: 55 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Ohr Pharmaceuticals, Inc.(OHRP)$ 8-K - Current report Filed: 2018-01-05 AccNo: 0001387131-18-000058 Size: 41 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Ohr Pharmaceuticals, Inc.(OHRP)$ 美东时间 2017-12-15 盘前 披露财报,预期EPS -0.08 网页链接